Importantly, depletion of IGFBP2 by siRNA reduced cell proliferation, enhanced apoptosis, and decreased migration and invasion of TSC2-null LAM patient-derived cells. This evidence concerns the gene IGFBP2 and lymphangioleiomyomatosis.